参考文献/References:
[1] 孙雪,任红霞.胆道闭锁发生与肝纤维化的分子机制研究进展[J].临床小儿外科杂志,2019,18(5):432-436.
[2] BOVEK E,THRASHER A D,ANDERS R,et al.Inflammation,active fibroplasia,and end-stage fibrosis in 172 biliary atresia remnants correlate poorly with age at kasai portoenterostomy,visceral heterotaxy,and outcome[J].Am J Surg Pathol,2018,42(12):1625-1635.
[3] 吕俊健,王哲,钟微.巨细胞病毒感染对胆道闭锁患儿葛西手术预后的影响[J].热带医学杂志,2019,19(8):1024-1027.
[4] ZHOU Y,LV X,QU H,et al.Preliminary screening and functional analysis of circular RNAs associated with hepatic stellate cell activation[J].Gene,2018,677:317-323.
[5] NAKANO Y,KAMIYA A,SUMIYOSHI H,et al.A deactivation factor of fibrogenic hepatic stellate cells induces regression of liver fibrosis in mice[J].Hepatology,2020,71(4):1437-1452.
[6] RAMOS-TOVAR E,FLORES-BELTRN R E,GALINDO-GO'MEZ S,et al.Stevia rebaudiana tea prevents experimental cirrhosis via regulation of NF-kappaB,Nrf2,transforming growth factor beta,Smad7,and hepatic stellate cell activation[J].Phytother Res,2018,32(12):2568-2576.
[7] FABREGAT I,CABALLERO-DAZ D.Transforming growth factor-β-induced cell plasticity in liver fibrosis and hepatocarcinogenesis[J].Front Oncol,2018,8:357.
[8] ANDUEZA A,GARDE N,GARCA-GARZO'N A,et al.NADPH oxidase 5 promotes proliferation and fibrosis in human hepatic ste-llate cells[J].Free Radic Biol Med,2018,126:15-26.
[9] YOSHIDA K,MATSUZAKI K,MURATA M,et al.Clinico-pathological importance of TGF-β/phospho-Smad signaling during human hepatic fibrocarcinogenesis[J].Cancers (Basel),2018,10(6):183.
[10] SYSA P,POTTER J J,LIU X,et al.Transforming growth factor-β1 up-regulation of human α1(I) collagen is mediated by Sp1 and Smad2 transacting factors[J].DNA Cell Biol,2009,28(9):425-434.
[11] 卢春远.基于TGF-β/Smads、ERK信号通路探讨委陵菜酸抑制肝星状细胞的作用及其机制[D].南宁:广西医科大学,2017.
[12] MAKINO Y,HIKITA H,KODAMA T,et al.CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression[J].Cancer Res,2018,78(17):4902-4914.
[13] KIM J,HYUN J,WANG S,et al.MicroRNA-378 is involved in hedgehog-driven epithelial-to-mesenchymal transition in hepatocytes of regenerating liver[J].Cell Death Dis,2018,9(7):721.
[14] CHEN Y,LI C,TAN C,et al.Circular RNAs:a new frontier in the study of human diseases[J].J Med Genet,2016,53(6):359-365.
[15] ZHANG Y,ZHANG X O,CHEN T,et al.Circular intronic long noncoding RNAs[J].Mol Cell,2013,51(6):792-806.
[16] TAULLI R,LORETELLI C,PANDOLFI P P.From pseudo-ceRNAs to circ-ceRNAs:a tale of cross-talk and competition[J].Nat Struct Mol Biol,2013,20(5):541-543.
[17] SUZUKI H,TSUKAHARA T.A view of pre-mRNA splicing from RNase R resistant RNAs[J].Int J Mol Sci,2014,15(6):9331-9342.
[18] NG W L,MOHD MOHIDIN T B,SHUKLA K.Functional role of circular RNAs in cancer development and progression[J].RNA Biol,2018,15(8):995-1005.
[19] GUO J,ZHOU Y,CHENG Y,et al.Metformin-induced changes of the coding transcriptome and non-coding RNAs in the livers of non-alcoholic fatty liver disease mice[J].Cell Physiol Biochem,2018,45(4):1487-1505.
[20] WANG Q,YU Y,ZHANG P,et al.The crucial role of activin A/ALK4 pathway in the pathogenesis of Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation[J].Basic Res Cardiol,2017,112(4):47.
[21] MAURICE D,PIERREUX C E,HOWELL M,et al.Loss of Smad4 function in pancreatic tumors:C-terminal truncation leads to decreased stability[J].J Biol Chem,2001,276(46):43175-43181.